Jeffrey S Barrett (Joan Korth-Bradley, Joan M Korth-Bradley, J Korth-Bradley)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Smoking Cessation

Atrial Fibrillation

Top Venues

Journal of clinical pharmacology

Haemophilia : the official journal of the World Federation of Hemophilia

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey S Barrett
Regulatory Framework for Drug Development in Rare Diseases. Journal of clinical pharmacology (2022)
Mark P Smith, Jeremy Rupon, Yasser Wali, Hala Rimawi, Jeffrey S Barrett, Lynne Smith, Pablo Rendo
Impact of treatment regimen with moroctocog alfa (AF-CC) on bleeding rates in paediatric patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 26 (5) (2020)
Jeffrey S Barrett
Perspective on Data-Sharing Requirements for the Necessary Evolution of Drug Development. Journal of clinical pharmacology 60 (6) (2020)
Jeffrey S Barrett
The Path to Perfect Pediatric Posology - Drug Development in Pediatrics. Journal of clinical pharmacology (2019)
L Rusen, Kaan Kavakli, Jeffrey S Barrett, F Huard, P Rendo, J Fuiman, J A Baumann, L Smith, C Alvey, Jeremy Rupon
Clinical experience with moroctocog alfa (AF-CC) in younger paediatric patients with severe haemophilia A: Two open-label studies. Haemophilia : the official journal of the World Federation of Hemophilia 24 (4) (2018)